• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pierre Fabre and Lonza Enter Manufacturing Agreement

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Qosina Strengthens Aseptic Capabilities

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Pierre Fabre and Lonza Enter Manufacturing Agreement

    Qosina Strengthens Aseptic Capabilities

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies

    Antheia Receives $40 million in Venture Debt Financing

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the U.S.

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IDT Biologika

    Kyongbo Pharmaceutical

    Biosynth Carbosynth

    Quotient Sciences

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    IDT Biologika

    Kyongbo Pharmaceutical

    Biosynth Carbosynth

    Quotient Sciences

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Leveraging Clinical Trial Outcomes Through Medication Adherence

    Addressing adherence and trial failure, the problem with traditional methods, and the smart way to monitor adherence.

    Leveraging Clinical Trial Outcomes Through Medication Adherence
    Related CONTENT
    • Jubilant HollisterStier
    • CPhI North America Travel
    • CPhI North America Event Info
    • Sensum
    • ViscoTec America Inc.
    Bernard Vrijens, CEO & Scientific Lead, AARDEX Group08.05.21
    Sponsors and regulators have long known that poor adherence to medication is a threat to clinical trial success. How to solve the problem, however, has not been so clear cut. Until now.

    In recent years, digital adherence monitoring, with its ability to track doses, trace drug taking behavior, and inform individualized interventions, has emerged as an evidence-based way to leverage clinical trial outcomes.

    In this article, we will set out the adherence problem, and how it can adversely affect research, before demonstrating how modern monitoring systems have the edge over traditional methods.

    Adherence and trial failure
    The reasons for study failure are as varied and complex as the trials themselves, but one common thread runs through many of them – poor medication adherence, which affects around 50% of all clinical trial participants.1

    According to a 2018 review of data from the previous 30 years, the primary source of trial failure is an inability to demonstrate efficacy .2  One study, by Hwang et al, of 640 Phase III trials of novel therapeutics, found that 54% had failed in clinical development. Of these, 57% were attributed to inadequate efficacy.3

    But this does not necessarily mean the drug did not work. The finding could, for example, be the result of incorrect dosing or an underpowered study,2 both of which are common consequences of poor medication adherence.

    Safety is another common cause of study collapse, with Hwang et al finding it to be the root cause of failure in 17% of the Phase III trials analysed.3

    However, unmanaged medication adherence often leads to distorted risks/benefits and safety concerns may be the result of the selection of an ill-fated dosing regimen or a total dose higher than needed for adherent patients.4

    With it taking between 10 and 12 years and more than £550million4 to develop a new drug, poor adherence to the trial protocol , then, is a costly problem.

    The problem with traditional methods
    Sponsors and CROs have grappled with the financial and logistical problems of poor medication adherence for decades.  

    To date, they have been forced to rely on the only methods available – pill counts, blood sampling, and HCP or self-reporting. Yet these traditional approaches are not sensitive enough to provide real value.

    Counting returned tablets is easily censored by participants. Moreover, it only provides a summary of adherence between site visits, rather than an overall understanding of treatment initiation and dosing patterns.

    Self-reporting, in which participants record their doses in a diary, for example, is vulnerable to inaccuracies, bias and places additional burden on the study participant. The same is true with different methods of diaries including paper and digital apps, even if they have reminders and other advanced technology that record proof of ingestion. Resulting in poor data quality and an increase in fraud due to patient inconvenience.5

    Similarly, monitoring drug or drug metabolites in blood, urine, or hair only provides a snapshot of adherence.  So-called “white coat adherence”, meaning people only take the investigational product the day before their site visit, is a concern. It is invasive, burdensome, and its use is largely restricted to active arms of a trial.

    The smart way to monitor adherence
    Digital monitoring using smart packages is frictionless for patients, thus objective & precise and provides a holistic view of medication taking behavior.

    The solution combines smart drug packaging, such as connected inhalers, blister packs, and container caps, with powerful data analytics.

    Microcircuitry in the packaging records automatically dose administration and transmits the information to the study team’s software. For example, connected pre-filled syringes collect and send essential information, including whether the injection was completed, and the time and date of administration.

    A cloud-based platform then uses sophisticated algorithms to analyze medication-taking behavior and uses data visualizations to flag any erratic dosing patterns.

    By identifying participants who may be at risk of poor-adherence, study teams can tailor to that individual’s personal non-adherence drivers. 

    This advanced approach is feasible, reliable, and easily implemented. It is continuous, meaning it provides an overall picture, and non-invasive, placing no additional burden on staff or participants.

    Crucially, it is evidence based. Studies have shown that smart package monitoring is 97% accurate, compared to 60% for pill counting, 50% for healthcare professional rating, and just 27% for self-reporting.6

    Digital adherence smart packaging solutions, then, provide sponsors and CROs with the tools they need to improve medication taking behaviors, mitigating the risk of study failure and increasing their return on investment.


    1. Eliasson, L., Clifford, S., et al. How the EMERGE guideline on medication adherence can improve the quality of clinical trials . (2020). https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14240
    2. Fogel, D. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. (2018).  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092479/
    3. Hwang, T., Carpenter., D.  et al. Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results. (2016)https://pubmed.ncbi.nlm.nih.gov/27723879/
    4. Breckenridge, A., Aronson, J., et al. Poor medication adherence in clinical trials: consequences and solutions. (2017).  https://www.nature.com/articles/nrd.2017.1?WT.ec_id=NRD-201703&spMailingID=53536275&spUserID=ODkwMTM2NjI2OQS2&spJobID=1120295377&spReportId=MTEyMDI5NTM3NwS2
    5. Larson., K, Areberg J., et al. Clinical Trials1–6. DOI: 10.1177/17407745211012683 journals.sagepub.com/home/ctj
    6. Greener, M. Drug development: bench to bedside. (2013) https://www.magonlinelibrary.com/doi/abs/10.12968/npre.2010.8.2.46589 visited on 19 May 2021.


    Dr. Vrijens holds a PhD from the Department of Applied Mathematics and Informatics at Ghent University, Belgium. He currently leads a research program investigating (a) the most common errors in dosing using a simple but robust taxonomy, (b) particular dosing errors that can jeopardize the efficacy of a drug, and (c) the optimal measurement-guided medication management program that can enhance adherence to medications and maintain long-term persistence. Dr. Vrijens is also the co-author of seven book chapters, over 100 peer-reviewed scientific papers, and named as inventor on 6 patents. He is a founding member of the International Society for Medication Adherence (ESPACOMP), and an active member of several EU- and US-funded collaborative projects around the theme of adherence to medications.

     
    Related Searches
    • Information Technology
    • Clinical Trials
    Suggested For You
    Jubilant HollisterStier Jubilant HollisterStier
    CPhI North America Travel CPhI North America Travel
    CPhI North America Event Info CPhI North America Event Info
    Sensum Sensum
    ViscoTec America Inc. ViscoTec America Inc.
    Ackley Machine Corporation Ackley Machine Corporation
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    Boyds Opens US Office in PA Boyds Opens US Office in PA
    GeneQuine, Exothera Enter Gene Therapy Partnership GeneQuine, Exothera Enter Gene Therapy Partnership
    Repligen and Navigo Launch Antibody Technology Platform Repligen and Navigo Launch Antibody Technology Platform

    Related Live From Shows

    • Jubilant HollisterStier

      Jubilant HollisterStier

      Jubilant HollisterStier is an integrated contract manufacturer of sterile injectables, ophthalmics, otics and sterile and non-sterile topicals and liquids.
      04.22.22

    • CPhI North America Travel

      CPhI North America Travel

      ...
      04.21.22

    • CPhI North America Event Info

      CPhI North America Event Info

      ...
      04.21.22


    • Sensum

      ...
      Marko Sraj, BDM 12.06.21

    • ViscoTec America Inc.

      ...
      Melanie Hintereder, Marketing 11.05.21

    Loading, Please Wait..
    Trending
    • Machine Learning-based Predictive Modeling: Notable Uses In Clinical Trials
    • Pierre Fabre And Lonza Enter Manufacturing Agreement
    • MilliporeSigma Opens $65M CDMO Facility For Cancer Therapies
    • 17th Annual Contracting & Outsourcing Conference Photos
    • Curia And Replicate Bioscience Enter SrRNA Collaboration
    Breaking News
    • Qosina Strengthens Aseptic Capabilities
    • Pierre Fabre and Lonza Enter Manufacturing Agreement
    • Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
    • MasterControl and Elemental Machines Form Biomanufacturing Partnership
    • MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Newsmakers: Darren Shirley
    • Are You Prepared for the 2023 DSCSA Deadline?
    • Rethinking the Changing Role of the CRO
    • 23rd Annual Salary Survey
    • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    • CEO Spotlight: David Chang
    • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
    • CRO Industry Market Report
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Florida Food Products Acquires Javo
    Roquette Launches Nutralys Rice Protein
    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    Coatings World

    Latest Breaking News From Coatings World

    The Southern Society for Coatings Technology's 84th Annual Technical Conference A Success
    PPG to Showcase Specialty Automotive, Aerospace Adhesives, Sealants at Adhesives & Bonding Expo
    PPG’s New Paint for a New Start Initiative to Transform 25-plus Schools Worldwide
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most Read Stories This Week—June 25
    Magnetic Insight Announces $17 Million in Series B Funding
    BreatheSuite Adds Brad Fluegel to its Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    MasterControl and Elemental Machines Form Biomanufacturing Partnership
    Qosina Strengthens Aseptic Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Benefit Exec Joins Madison Reed's Board
    Peroni & Ellis Brooklyn Launch Fragrance Collection Inspired by Italian Spritz Cocktails
    Rhode Is Trending for June, Trendalytics Says
    Happi

    Latest Breaking News From Happi

    Spate’s Nose for the Latest Beauty Trends Says The Skunk Stripe, Collagen Serum and Waterproof Eyeshadow are Top of Mind for Consumers this Summer
    A Suitor Emerges for Revlon, SK Capital’s New Dealmaker & P&G’s Indoor Air Quality Efforts
    Wonder Curl Wins GlossWire's GlossPitch Competition
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    British Coatings Federation Posts Online History
    Orion Announces Price Increases, Reduced Payment Terms
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PCMC teams with IGT, Fujifilm makes big announcement and more
    Loftware recognized as 'AIDC Company of the Year'
    Schreiner MediPharm highlights sustainability of Needle-Trap technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
    Tranzonic Names VP of Supply Chain
    Ontex Climate Action Targets Approved by Science-Based Targets Initiative
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—June 25
    3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
    Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories
    NREL Names Jennifer Logan to Leadership Team as CFO
    National Grid Renewables Orders 2 GW of First Solar Modules

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login